跳至主要内容
临床试验/NCT00654511
NCT00654511已完成4 期

Dexmedetomidine for Immediate Perioperative Analgesia in Pediatric Patients Undergoing Tonsillectomy.

Children's National Research Institute1 个研究点 分布在 1 个国家目标入组 101 人开始时间: 2005年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
101
试验地点
1
主要终点
Time to First Morphine Dose

研究概览

简要总结

The primary purpose of this study is:

  1. To compare dexmedetomidine with fentanyl in terms of intra-operative hemodynamics and post-operative analgesia.
  2. To determine an analgesic dose response relationship for dexmedetomidine.
  3. Compare recovery characteristics of dexmedetomidine to fentanyl.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
2 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • All of the following criteria must be met for the potential subject to be eligible for participation:
  • The subject is 2 to 12 years of age
  • The subject's American Society of Anesthesiologists physical status is ASA I or II (see appendix 1).
  • The subject is scheduled for elective tonsillectomy with or without adenoidectomy surgery (procedures with myringotomy tube placement are allowed).
  • The subject will be hospitalized overnight after surgery
  • The subject's parent/legally authorized guardian has given written informed consent to participate; and where applicable, the subject has given appropriate assent to participate.

排除标准

  • The potential subject is NOT eligible for participation if any of the following exclusion criteria apply:
  • The subject has a history or a family (parent or sibling) history of malignant hyperthermia
  • The subject has known significant renal or hepatic disorders determined by medical history, physical examination or laboratory tests.
  • The subject has a known or suspected allergy to opioid analgesics
  • The subject is a pregnant or lactating female (if post-menarcheal, a negative pregnancy test must be confirmed prior to the planned surgery time (in AMSAC) consistent with current standard of care.
  • The subject has history of. cardiovascular issues which would preclude the use of dexmedetomidine, (e.g. Down's Syndrome, dysrhthymias, conditions where hypotension is to be avoided).

研究组 & 干预措施

Fentanyl 1

Active Comparator

Fentanyl 1 micrograms (mcg)/kilogram (kg)

干预措施: Fentanyl (Drug)

Fentanyl 2

Active Comparator

Fentanyl 2 micrograms (mcg)/kilogram (kg)

干预措施: Fentanyl (Drug)

Dex 3

Experimental

Dexmedetomidine 2 micrograms (mcg)/kilogram (kg)

干预措施: Dexmedetomidine (Drug)

Dex 4

Experimental

Dexmedetomidine 4 micrograms (mcg)/kilogram (kg)

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Time to First Morphine Dose

时间窗: up to 24 hours

Total minutes from study medication administration to time of first morphine dose.

Morphine Rescue

时间窗: up to 24 hours

Total morphine administered in the Post Anesthesia Care Unit (PACU)

次要结局

未报告次要终点

研究者

发起方
Children's National Research Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Julia Finkel

MD

Children's National Research Institute

研究点 (1)

Loading locations...

相似试验